Table 4.

Clinical outcomes.

	NI-NAVA (n = 13)	NIPPV (n = 13)	P value
Sepsis	0 (0)	1 (8)	0.25*
Pneumonia	2 (15)	1 (8)	0.25*
IVH grade 3/4	1 (8)	1 (8)	1.0***
Air leaks	0 (0)	1 (8)	0.31*
BPD moderate/severe	4 (31)	6 (46)	0.42*
NEC (≥stage 2)	1 (8)	1 (8)	1.00*
PDA moderate/large	6 (46)	5 (42)	0.82*
PDA (medically treated)	2 (15)	2 (15)	0.96*
ROP > stage 2	3 (23)	2 (15)	0.62*
Days of caffeine usea	42 (29, 49)	41 (24, 50)	0.57**
Use of chronic diuretics post study extubation	5 (38)	5 (38)	0.58*
Days on chronic diuretics post study extubationa	58 (18,60)	18 (15, 39)	0.30**
Steroid use post study extubation	4 (31)	2 (15)	0.35*
Days of steroid use post study extubationa	10 (10,15)	8 (8,10)	0.17**
Length of staya	78 (58,87)	67 (56,99)	0.71**
Weight (g) at 36 weeks’ PMAa	2134 (1980, 2357)	1978 (1823, 2140)	0.24**
Length (cm) at 36 weeks’ PMAa	44 (42, 46)	43 (41, 44)	0.27**
Head circumference (cm) at 36 weeks’ PMAa	31 (30, 31.5)	30.5 (29, 31)	0.53**

Data are presented as counts (percentages) unless specified

PMA postmenstrual age

*Pearson’s Chi-square; **Wilcoxon rank sum test, ^#p < 0.05, ***Fisher’s exact

^aMedian (1st quartile, 3rd quartile)